N A Brophy
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 6
- Drug Transport and Resistance Mechanisms 5
- Lung Cancer Research Studies 2
-
- Neuroendocrine Tumor Research Advances 2
- Hepatitis B Virus Studies 1
- Co-authors
- Branimir I. Šikić (9 shared papers)Joanne Halsey (7 shared papers)George A. Fisher (7 shared papers)B L Lum (5 shared papers)Michael P. Gosland (2 shared papers)Sonja Kaubisch (2 shared papers)Nancy L. Bartlett (1 shared paper)Marc Peters‐Golden (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (2 papers)Anti-Cancer Drugs (2 papers)British Journal of Haematology (1 paper)The American Journal of Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
N A Brophy
13 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Oncology 728
- Pediatrics, Perinatology and Child Health 214
- Biotechnology 85
- Pharmacology 71
- Hematology 87
Countries citing papers authored by N A Brophy
This map shows the geographic impact of N A Brophy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N A Brophy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N A Brophy more than expected).
Fields of papers citing papers by N A Brophy
This network shows the impact of papers produced by N A Brophy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N A Brophy. The network helps show where N A Brophy may publish in the future.
Co-authors
The 25 scholars most cited alongside N A Brophy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 263 | |
| 2 | 1992 | 200 | |
| 3 | Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. | 1987 | 184 |
| 4 | 1994 | 165 | |
| 5 | 1993 | 128 | |
| 6 | 1988 | 87 | |
| 7 | 1990 | 84 | |
| 8 | 2004 | 61 | |
| 9 | 1992 | 38 | |
| 10 | 2000 | 38 | |
| 11 | 1994 | 9 | |
| 12 | 1994 | 6 | |
| 13 | 1994 | 3 |
About N A Brophy
N A Brophy is a scholar working on Oncology, Epidemiology, Surgery, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 13 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Lung Cancer Research Studies (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer therapeutics and mechanisms (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers), Hepatitis B Virus Studies (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (728 citations), Pediatrics, Perinatology and Child Health (214 citations), Biotechnology (85 citations), Pharmacology (71 citations) and Hematology (87 citations). N A Brophy has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Branimir I. Šikić, Joanne Halsey, George A. Fisher, B L Lum, Michael P. Gosland, Sonja Kaubisch, Nancy L. Bartlett, Marc Peters‐Golden, Christine Siegert and Thomas R. Gravelyn. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Anti-Cancer Drugs, British Journal of Haematology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.